美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NLS Pharmaceutics Ltd. Warrant

0.0179

0.0000

成交量：- -

成交額：- -

市值：6.51萬

市盈率：-0.01

高：0.0179

開：0.0179

低：0.0179

收：0.0179

52周最高：0.0400

52周最低：0.0009

股本：363.64萬

流通股本：363.64萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.0387

淨資產收益率：-862.92%

總資產收益率：-75.98%

市淨率：0.02

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

NLS Pharmaceutics Ltd. 宣佈進行1比10的反向股票拆分並更改名稱，以配合與Kadimastem的擬議合併

NLS Pharmaceutics與Kadimastem宣佈Kadimastem與Targetgene之間的戰略合作，以推動下一代基因編輯細胞療法

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NLSPW"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NLSPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSPW\",,,,,undefined,":{"symbol":"NLSPW","market":"US","secType":"STK","nameCN":"NLS Pharmaceutics Ltd. Warrant","latestPrice":0.0179,"timestamp":1770670800000,"preClose":0.0179,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":3636363,"shares":3636363,"eps":-2.0387,"marketStatus":"停牌","change":0,"latestTime":"02-09 16:00:00 EST","open":0.0179,"high":0.0179,"low":0.0179,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.0387,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":0.0179,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSPW\",,,,,undefined,":{"symbol":"NLSPW","floatShares":3636363,"roa":"-75.98%","roe":"-862.92%","lyrEps":0,"shares":3636363,"dividePrice":0,"high":0.0179,"amplitude":0,"preClose":0.0179,"low":0.0179,"week52Low":0.0009,"pbRate":"0.02","week52High":0.04,"institutionHeld":0,"latestPrice":0.0179,"eps":-2.0387,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.0387,"open":0.0179,"prevYearClose":0.0179,"prevWeekClose":0.0179,"prevMonthClose":0.0179,"prevQuarterClose":0.0179,"fiveDayClose":0.0179,"twentyDayClose":0.0179,"sixtyDayClose":0.0179},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLSPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLSPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLSPW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NLSPW\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171878787","title":"NLS Pharmaceutics Ltd. 宣佈進行1比10的反向股票拆分並更改名稱，以配合與Kadimastem的擬議合併","url":"https://stock-news.laohu8.com/highlight/detail?id=1171878787","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171878787?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 18:00","pubTimestamp":1761732022,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称，以配合与Kadimastem的拟议合并。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","NLSP","BK4007","NLSPW"],"gpt_icon":0},{"id":"1131118792","title":"NLS Pharmaceutics與Kadimastem宣佈Kadimastem與Targetgene之間的戰略合作，以推動下一代基因編輯細胞療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1131118792","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131118792?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 19:02","pubTimestamp":1761562934,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作，以推动下一代基因编辑细胞疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","BK4007","NLSPW","NLSP"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NLSPW\",params:#limit:6,delay:false,,,undefined,":[]}}